Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-000784-41Phase 3Terminated
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Vaminolac with Placebo (2 arms). Primary endpoints: Palmitate balance by tracer kinetics, Tyrosine balance by tracer kinetics and 1 more. Started Jan 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-000784-41.